Slide 1: March 2014
For personal use only March 2014 www.dorsavi.com 1
Slide 2: Disclaimer
For personal use only DISCLAIMER This information is private and confidential and is proprietary to dorsaVi Ltd (dorsaVi). This information is provided to you by dorsaVi on the basis that you are a holder of an Australian financial services licence (AFSL), or a representative of the holder of an AFS
Slide 3: Introduction
Introduction For personal use only World first technology using sensors to capture and assess dorsaVi Limited ASX:dvl human movement, enabling many aspects of detailed Share price $0.48 (issue price 40 human movement and position to be accurately captured, cents) quantified and assessed outside a bi
Slide 4: Progress since IPO
Progress since IPO Corporate For personal use only Raised $18 million via an oversubscribed IPO and listed on ASX. Established UK/European subsidiary dorsaVi Europe Ltd. Expansion of direct sales force Australia: Recruitment progressing well for expanded sales and business development team with stro
Slide 5: Progress since IPO
Progress since IPO For personal use only US Launch imminent for ViPerform ViPerform is registered with FDA and is exempt from requiring 510k submission. Product launch ready with senior executive and 2 clinically trained sales people. FDA regulatory submission for ViMove progressing with 3rd round q
Slide 6: The old way to measure movement
The old way to measure movement For personal use only High tech laboratory systems that are not portable: • Time consuming for assessment. • Expensive. • Artificial setting. • Up to 2 days for results. 6 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 7: Capture accurate data inside and outside
Capture accurate data inside and outside For personal use only Movement Sensor The Recording and Feedback Device Muscle Sensor Captures wireless data for 24 hours Able to display live data 7 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 8: Fundamental applications of the system
Fundamental applications of the system For personal use only In the clinic In real life 1. Live Assessment 2. Monitoring Data 3. Live Training 4. Biofeedback Therapy 8 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 9: Every person's movement is unique
Every person’s movement is unique JUST LIKE THEIR FINGERPRINT For personal use only dorsaVi has three ground breaking products: Elite and professional sports clubs Physiotherapists and clinicians Occupational health and safety 9 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 10: For personal use only
For personal use only
Slide 11: Every sport has a different 'movement signature'
Every sport has a different ‘movement signature’ For personal use only AUSTRALIAN clients New customers UNITED KINGDOM clients New customer 11 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 12: Sport
For personal use only Sport 12
Slide 13: ViPerform addresses multiple elements of injury management and performance
ViPerform addresses multiple elements of injury management and performance For personal use only Improve technique “Sports coaches can use ViPerform to screen their entire team and potential recruits, Richmond Reduce risk of injury Football Club has been innovative in its adoption of ViPerform and u
Slide 14: Knee In The Gym Assessment / Hamstring Live Training
For personal use only Knee In The Gym Assessment Hamstring Live Training 14
Slide 15: Benefits of Elite Sports Business
Benefits of Elite Sports Business For personal use only Strong Validation Used by leading experts in their fields. Branding & Strong reputation source driving referrals. Referrals Creates New Products and IP Keeps dorsaVi at the cutting edge. Drives Mass Market Builds awareness for consumer
Slide 16: For personal use only
For personal use only 16
Slide 17: Clinical
For personal use only Clinical 17 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 18: Medical Market
Medical Market 60 Reduced Pain by 46% 50.7 For personal use only 50 Clinically validated 2% Control QVAS • Clinical trial undertaken at 8 sites including the Austin 40 and Epworth Hospitals. • 103 subject Randomised Controlled Trial with 51 30 27.4 control and 52 intervention subjects. 46% • Signifi
Slide 19: Protocol Based Treatment
Protocol Based Treatment For personal use only Medical Physio Assessment Treatment Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Week 9 Week 10 Week 12 3 Medical & 8 Physio sessions over 12 weeks Standardised report provides common language 19 Copyright dorsaVi Ltd 2014. Commercial in Conf
Slide 20: Driving sales and product awareness
Driving sales and product awareness For personal use only • Direct sales force in Australia, US and UK established and expanding over the year: • Currently hiring sales professionals across major states in Australia; • Three sales people appointed in the UK and a further 2 in Europe; and • Two sales
Slide 21: Compelling Value for Physios
Compelling Value for Physios For personal use only Common Language Standardised metrics between Doctors & Physios. Increased Referrals Physicians and Doctors now referring based on defined protocol. More Revenue per Patient Patients finish course of treatment. Patient Loyalty and Lock in His
Slide 22: Scale Up for the Medical/Physiotherapy Market
Scale Up for the Medical/Physiotherapy Market For personal use only • Public awareness campaigns Marketing • Existing high profile clients • KOLs speaking at local & international conferences • Charging more per session Earning Potential • Passive income • Additional tests Increasing Value • Exercis
Slide 23: ViMove Running Product Launch
ViMove Running Product Launch • Example of adapting existing products to For personal use only particular sports. • Successful pilot program ran in conjunction with Olympic Park Sports Medicine Centre. • Broader launch this week: • Targeting 15 physiotherapy / sports medicine clinics. • Incentives t
Slide 24: ViMove Running
ViMove Running For personal use only 24 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 25: ViPerform ViMove Module
ViPerform ViMove Module • US – Knee prevention application For personal use only • Validates uniqueness • Relevant across many sports • Perfect for physio & medical market • Denmark – Cervical Spine application • Interest from leading Scandinavian Uni • Funds R&D project • Ideal for Clinical and OH&
Slide 26: For personal use only
For personal use only
Slide 27: OH&S
OH&S For personal use only 27 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 28: Identifying and reducing workplace risk
Identifying and reducing workplace risk For personal use only New contracts secured Stage 1: Solution focused BHP, Woolworths, Amcor Scaled business Large projects and/or annuity Toyota, Wesfarmers, Toll, Crown with large companies Stage 2: Work with large Leverage distribution channels Worksafe, IS
Slide 29: Business model and pricing
For personal use only Business model and pricing Business Model for ViMove and ViPerform • Licence model $5,000 – 7,500 p.a. per unit + consumables • Value add with personalised web-based exercises • Annuity based Business Model for ViSafe • Project based fee • Baseline assessment (Stage 1 & 2) $20,
Slide 30: dorsaVi's Global Strategic Initiatives
dorsaVi’s Global Strategic Initiatives For personal use only Research – Clinical Trials Guide clinical research projects in line with dorsaVi goals Reimbursement Identify existing item codes that fit ViMove uses Education Educate the next generation of clinicians Awareness – Market Entry Eng
Slide 31: dorsaVi's Strategy and International Launch
dorsaVi’s Strategy and International Launch For personal use only Australia – perfect test market, R&D for new product, base revenue Europe – Clinical & Sports Sales Team, elite level intel feeds R&D (now) US - Clinical & Sports Sales Team, elite level intel feeds R&D (3 months) UK, Germany and Scan
Slide 32: The Consumer market
The Consumer Consumer For personal use only market Medical Elite Sports OH&S 32 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 33: Hot space to be in
For personal use only Hot space to be in INSPIRING THE WORLD TO MOVE 33 Copyright dorsaVi Ltd 2014. Commercial in Confidence
Slide 34: Where is dorsaVi positioned in wearable sensors market?
Gimmick Data at 4-10Hz $200-400 purchase price Where is dorsaVi positioned in Simple data No reference to normal data wearable sensors market? For personal use only Data at 200Hz $7k cost Market Immediate results Opportunity Specialist quality data Lab quality Data at 1000Hz $500k set up cost Days t
Slide 35: Financial Snapshot
Financial Snapshot 2011 2012 2013 H1 2014 For personal use only Revenue Sales revenue 65,368 244,471 398,607 387,127 EBITDA (903,107) (2,332,015) (2,148,749) (1,290,000) Loss from continuing (489,409) (1,510,166) (1,659,235) (1,074,000) operations Cash position $16.63M Increase marketing using hig
Slide 36: News Flow
News Flow For personal use only Next 12 months Numerous major industry conference presentations New OH&S contracts with large Australian companies Partnership with major insurers Additional Australian / UK Elite Sports sign ups New high calibre hires FDA approval of ViMove Initial sales into the US
Slide 37: Board of Directors
Board of Directors For personal use only Chairman, Herb Elliott AC MBE Olympic Gold Medallist (Rome 1960), Deputy Chairman of Fortescue Metals Group Limited; Former Director of Ansell, Former President of Puma Nth America and Former Director of Pacific Dunlop Ltd Non Executive Director, Greg Tweedly
Slide 38: Questions?
Questions? Value Proposition Disruptive Multiple For personal use only Technology Markets Markets Annuity Cross Business Fertilise Model Medical Elite Strong Key Sports Barriers to Customers Entry OH&S Board and Clinical and Management regulatory Team 38 Copyright dorsaVi Ltd 2014. Commercial in Con